2nd NovAliX Conference - Biophysics in Drug Discovery 2015

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

BφDD 2015

 Strasbourg, France    June 9-12, 2015

Committees


Conference Chairman

Dr Jean-Paul RENAUD

Illkirch, France

Scientific Committee

Dr Ursula EGNER

Bayer, Berlin, Germany

Dr Michael HENNIG

F. Hoffmann-La Roche Ltd., Villigen, Switzerland

Dr Geoff HOLDGATE

AstraZeneca, Macclesfield, United Kingdom

Prof. Rod HUBBARD

University of York & Vernalis, Cambridge, United Kingdom

Dr Vincent MIKOL

Sanofi, Vitry-sur-Seine, France

Dr Herbert NAR

Boehringer Ingelheim, Biberach, Germany

Dr Johannes OTTL

Novartis Institute of Biomedical Research, Basel, Switzerland

Dr Jean-Paul RENAUD

Illkirch, France

Dr Edward ZARTLER

Quantum Tessera Consulting, Collegeville, PA, United States